Smofkabiven Peripheral Special Precautions

Tell the doctor if the patient has: kidney problems; diabetes mellitus; pancreatitis (inflammation of the pancreas); liver problems; hypothyroidism (toxic goiter); sepsis (serious infection).
If the patient during the infusion gets fever, rash, swelling, difficulty in breathing, chills, sweating, nausea or vomiting, tell the health care professional immediately because these symptoms might be caused by an allergic reaction or that the patient has been given too much of the medicine.
The doctor may regularly need to check the blood for liver function tests and other values.
SmofKabiven Peripheral is not meant for newborn babies or children younger than 2 years of age. At the moment, there is no experience of the use of SmofKabiven Peripheral in children from 2 to 11 years old.
To avoid risks associated with too rapid infusion rates, it is recommended to use a continuous and well-controlled infusion, if possible, by using a volumetric pump.
Since an increased risk of infection is associated with the use of any peripheral vein, strict aseptic precautions should be taken to avoid any contamination especially during catheter insertion.
Serum glucose, electrolytes and osmolarity as well as fluid balance, acid-base status and liver and enzyme tests should be monitored.
Any sign or symptom of anaphylactic reaction (such as fever, shivering, rash or dyspnoea) should lead to immediate interruption of the infusion.
SmofKabiven Peripheral should not be given simultaneously with blood in the same infusion set due to the risk of pseudoagglutination.
Thrombophlebitis may occur if peripheral veins are used for infusions. The catheter insertion site should be evaluated daily for local signs of thrombophlebitis.
Driving and using machines: Not relevant as the medicine is given at the hospital.